Výsledky vyhledávání - "Emily Lorber"

Akademický článek

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

Autor: Madalina Tuluc, Ioannis A Vathiotis, Joseph Curry, Jennifer M Johnson, Ayesha Ali, Larry A Harshyne, Voichita Bar Ad, Rita Axelrod, Emily Lorber, David M Cognetti, Adam J Luginbuhl, Scott Keith, Mỹ G Mahoney, Athanassios Argiris

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)

Background The combination of nivolumab and ipilimumab has been approved for the treatment of multiple solid tumors. This was a phase I study investigating definitive radioimmunotherapy (RIT) with nivolumab and ipilimumab for the treatment of locally

Externí odkaz: https://doaj.org/article/4fbfb90b2ba3402e9ed28e81355be521

Zobrazit plný text záznamu

869P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot study

Autor: Dawn Poller, Scott W. Keith, David Cognetti, Joseph Curry, Jennifer Johnson, Voichita Bar-Ad, Rita Axelrod, A. Ali, Adam Luginbuhl, Emily Lorber, Athanassios Argiris

Publikováno v: Annals of Oncology. 32:S791

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e69e00aefb153b265737149d7f7ab864
https://doi.org/10.1016/j.annonc.2021.08.1279

Zobrazit plný text záznamu

Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

Autor: Scott W. Keith, David Cognetti, Dawn Poller, Athanassios Argiris, Ulrich Rodeck, Rita Axelrod, Adam Luginbuhl, Joseph Curry, Emily Lorber, Larry Harshyne, Jennifer Johnson, Voichita Bar Ad, Gregor Manukian

Publikováno v: Journal of Clinical Oncology. 38:6577-6577

6577 Background: Immune checkpoint inhibitors (ICI) are the standard of care in recurrent/metastatic SCCHN but their role in the curative therapy setting with RT is under study. We evaluated the novel approach of combining Nivo, a PD-1 inhibitor, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c99489b3ff24a9146a8a89f7c213c143
https://doi.org/10.1200/jco.2020.38.15_suppl.6577

Zobrazit plný text záznamu

Safety of nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

Autor: Athanassios Argiris, Adam Luginbuhl, Ulrich Rodeck, Jennifer Johnson, Joseph Curry, Ralph Zinner, Voichita Bar Ad, Dawn Poller, Scott W. Keith, David Cognetti, Rita Axelrod, Emily Lorber, Larry Harshyne

Publikováno v: Journal of Clinical Oncology. 37:6070-6070

6070 Background: Standard cisplatin-based chemoradiotherapy for LA SCCHN is associated with toxicity and less than desirable survival in high-risk patients (pts). The combination of the anti-PD1 antibody nivolumab (nivo) and the anti-CTLA-4 antibody

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7053af30bd44e56d20b5275bdf493778
https://doi.org/10.1200/jco.2019.37.15_suppl.6070

Zobrazit plný text záznamu

Nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced head and neck cancer

Autor: Ulrich Rodeck, Adam Luginbuhl, V. Bar Ad, Larry Harshyne, Joseph Curry, Jennifer Johnson, Rita Axelrod, Emily Lorber, Athanassios Argiris, Scott W. Keith, David Cognetti, Ralph Zinner

Publikováno v: Annals of Oncology. 29:viii399

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4aaee494e78561619776f3c2f70626e6
https://doi.org/10.1093/annonc/mdy287.082

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání